Loading
Latest filing published 17 Mar 2023 for Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)).
No signal scores available.
All filings by Anthony Edward Dobranowski on record concern Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)). In total, 3 filings cover trades dated 14 March 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 17 March 2023: a transaction, in Aralez Pharmaceuticals Canada Inc. (formerly Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare)). Between a trade and the moment it shows up on SEDI, the median delay is 3 days. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations